Colgate-Palmolive (CL) Misses Q1 EPS by 2c, provides outlook

Colgate-Palmolive (NYSE: CL) reported Q1 EPS of $0.85, $0.02 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $4.91 billion versus the consensus estimate of $4.89 billion.

Full Year 2025 Guidance

Based on current spot rates and including the estimated impact of tariffs announced and in effect as of April 24, 2025:

The Company now expects net sales to be up low single digits, including a low-single-digit negative impact from foreign exchange.
The Company now expects organic sales growth to be 2% to 4%.
On a GAAP basis, the Company now expects both gross profit margin and advertising investment to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.
On a non-GAAP (Base Business) basis, the Company now expects both gross profit margin and advertising to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.

For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
• Lowe's slashes full-year sales outlook amid DIY spending pressure